West Pharmaceutical Services, Inc. (NYSE:WST), a global company involved in innovative solutions for injectable drug administration, announced on Friday that it has received approval from its board of directors for its second-quarter 2023 dividend.
The company has approved a second quarter dividend of USD0.19 per share.
The dividend will be paid to shareholders of record at 26 April 2023 on 3 May 2023.
Lilly and EVA Pharma partner to expand baricitinib access in Africa
Zimmer Biomet announces Q3 2024 quarterly cash dividend
Medtronic announces Q2 2025 cash dividend